Master multiplex assay design for drug discovery

Everything you need to know when choosing a multiplex immunoassay for your drug discovery program

21 Mar 2022

For high-throughput screening to be an effective tool for identifying promising candidates in drug discovery, it requires scalable, high-quality immunoassays to identify the candidates quickly, efficiently, and with minimal costs.

In this free application guide, find out how multiplexing can address those challenges by enabling you to measure multiple target analytes in a single reaction, exponentially increasing the number of data points collected whilst reducing workflow and sample volumes. Plus, discover the key considerations when choosing a multiplex assay and a comprehensive overview of the various multiplex assay techniques used in screening.

FirePlex® ​​Multiplex miRNA assays

Abcam plc

Multiplex miRNA assays with FirePlex particle technology enables simultaneous profiling of 65 miRNAs directly from small amounts of biofluid or FFPE, without RNA purification or pre-amplification, with assay readout on a standard flow cytometer

(1)

Links

Tags

Master multiplex assay design for drug discovery